Evaluation of the Antifungal Effect of Rhus verniciflua Stokes Extract for Oral Application Potential

Medicina (Kaunas). 2023 Sep 11;59(9):1642. doi: 10.3390/medicina59091642.

Abstract

Background and Objectives: This study confirms the possibility of using Rhus verniciflua Stokes (RVS) extract as a natural treatment for oral candidiasis. Materials and Methods: RVS was extracted with 70% ethanol to examine the antioxidant activity through polyphenol, flavonoid content, and DPPH (1,1-diphenyl-2-picrylhydrazyl). To evaluate the antifungal effect against Candida albicans (C. albicans; KCTC 7965/ATCC 10231) and evaluate the stability of RVS, a water-soluble tetrazolium salt (WST-1) assay was performed in human keratinocytes (HaCaT). Results: The findings revealed that RVS extract has fairly high antioxidant activity. The clear zones of the RVS extract against C. albicans increased in diameter due to the inhibition of fungal growth at higher concentrations. Treatment with the 1.25 mg/mL RVS extract had a more than 99% antifungal effect against C. albicans, and the 20 mg/mL RVS extract had a 100% antifungal effect. The WST-1 assay showed that the RVS extract induced low cell viability in the HaCaT cells, which inhibited their proliferation, and the RVS extract is also toxic to normal cells. Conclusions: Although the RVS extract with high antioxidant activity showed clear antifungal activity against C. albicans, it exhibited a low survival rate. Therefore, the development of a safe natural antibiotic is necessary.

Keywords: Candida albicans; Rhus verniciflua Stokes; antifungal effect; antioxidant; oral health.

MeSH terms

  • Anti-Bacterial Agents
  • Antifungal Agents* / pharmacology
  • Antioxidants / pharmacology
  • Humans
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Rhus*

Substances

  • Antifungal Agents
  • Antioxidants
  • Anti-Bacterial Agents
  • Plant Extracts

Grants and funding

This research received no external funding.